Anthrax- especially dangerous infection in clinical practice
Abstract
In article tactics of rendering medical aid to the anthrax patient is submitted. The brief characteristic of organizational actions is given at treatment of 7 patients with this especially dangerous infection. On a clinical example anthrax rare complication as a gastric bleeding is shown. Endoscopic picture of plural ulcer defects in a stomach differs that on periphery of ulcer inflammatory infiltration shaft is absent, and ulcer surfaces are covered with necrotic scab. Tactics of anthrax patient treatment complicated with a bleeding is shown.
References
1. Abramova F.A. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak in 1979 / F.A. Abramova, L.M. Grinberg, O.V. Yampolskaya // Proc Natl Acad Sci USA .-1993.- Vol. 90.-P.2291-2294.
2. Brachman P.S. Anthrax /P.S. Brachman //Plotkin & Mortimer, ed. Vaccines. Philadelphia (PA): W.B. Saunders; 1994. p. 730.
3. Caksen H. Cutaneous anthrax in eastern / H.Caksen, F.Arabaci, M. Abuhandan // Turkey. Cutis 2001.-Vol. 67.-P.488-492.
4. Cieslak T.J. Jr. Clinical and Epidemiologic Principles of Anthrax / T.J.Cieslak, E.M.Eitzen // Emerg Infect Dis.- 1999.-№.5.-P.552-555.
5. Danies J.C. A major epidemic of anthrax in Zimbabve / J.C.Danies // Centr Afr J Med.-1982.- №28.-P.291-298.
6. Dodanay M. Primary throat anthrax. A report of six cases / M. Dodanay, A.Almac, R.Hanagasi // Scand J Infect Dis.- 1986.-№ 18.-P.415-419.
7. Duesbery N.S. Proteolitic inactivation of MAP-kinase-kinase by anthrax lethal factor / N.S. Duesbery, C.P.Webb, S.H.Leppla // Scienсe.- 1998.-Vol. 280.-P.734-737.
8. Friedlander A.M. Anthrax / A.M. Friedlander // Sidell F.R., Takafuji E.T., Franz D.R., editors. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of the Surgeon General, US Dept of the Army.- 1997.-P.467-478.
9. Hanna P. How anthrax kills / P.Hanna // Science.- 1998.-Vol. 280.-P.1671-1673.
10. Harrison L.H. Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay / L.H.Harrison, J.W.Ezzell // J Infect Dis. - 1989.-Vol. 160.-P.706-710.
11. Inglesby T.V. Anthrax as a biological weapon: medical and public health management / T.V.Inglesby, D.A.Henderson, J.G.Bartlett // JAMA. - 1999.-Vol. 281.-P.1735-1745.
12. Lew D.P. Bacillus anthracis (Anthrax) / D.P. Lew // Mandell G.L., Bennett J.E., Dolin R. Principles and practice of infectious diseases. 5th ed. V. 2. p. 2215-2220.
13. Ndyabahinduka D.G.K. An outbreak of human gastrointestinal anthrax / D.G.K. Ndyabahinduka, I.H.Chu, A.H.Abdou // Ann Ist Super Sanita.-Vol.- 1984.-№ 20.-P.205-208.
14. Singh Y. A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo / Y.Singh, H.Khanna, A.P.Chopra // J Biol Chem 2001. - Vol.276.-P.290-294.
15. Smego R.A. Cutaneous Manifestation of Anthrax in Rural Haiti / R.A. Smego, B.Gebrian, G. Desmangels // Clin Infect Dis. - 1998.-Vol. 26.- P.97-102.
16. Turnbull P.C.B., Kramer J.M. Bacillus / Turnbull P.C.B., J.M. Kramer // Balows A., Hausler W.J.Jr., Herrmann K.L., [et al.]. Manual of Clinical Microbiology, 5th ed. Washington, DC, American Society for Microbiology; 1991. p. 296-303.
Review
For citations:
Plehanov A.N. Anthrax- especially dangerous infection in clinical practice. Yakut Medical Journal. 2011;(3):61-65.
Views:
25
Email this article 